Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2012
05/02/2012CN101534801B Protein-containing substance with increased thermal stability
05/02/2012CN101519439B Freezeproof polypeptide, synthesis, composition containing same and application thereof
05/02/2012CN101519437B Cyclic heptapeptide compound in Hsisha sponge and application thereof
05/02/2012CN101502641B Ciclosporin medicament composition for injection administration
05/02/2012CN101372513B Sg fusion protein
05/02/2012CN101353378B Zone 2 protein of programmed cell death protein 2 analogue and uses thereof
05/02/2012CN101270160B Monoclone antibody 1F1, uses thereof and hybridoma cell line BCSP31-1F1 excreting the antibody
05/02/2012CN101144061B Yeast engineering bacterium for producing human pepsinogen and its preparation method and application
05/02/2012CN101045156B Special target medicine and its use
05/02/2012CA2719855A1 Temperature sensitive hydrogel and block copolymers
05/01/2012USRE43331 Stabilized liquid protein formulations in pharmaceutical containers
05/01/2012US8168776 Method for making a 21 nucleotide double stranded RNA chemically linked at one end
05/01/2012US8168770 Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens
05/01/2012US8168753 Thrombin cleavable factor X analogues
05/01/2012US8168751 Interferon alpha mutant and its polyethylene glycol derivative
05/01/2012US8168623 Prodrugs of GABA analogs, compositions and uses thereof
05/01/2012US8168619 Hormonal composition based on a progestational agent and an oestrogen and use thereof
05/01/2012US8168599 Composition and method for healing tissues
05/01/2012US8168594 Method for treating celiac disease
05/01/2012US8168593 Mutated netrin-4, fragments thereof and their use as medicines
05/01/2012US8168592 CGRP peptide antagonists and conjugates
05/01/2012US8168591 Compositions and methods related to anti-FGF agents
05/01/2012US8168590 Use of proteolysis resistant active VEGF
05/01/2012US8168589 Use of erythropoietin and substances increasing and/or prolonging the activation and/or stimulation of erythropoietin receptors for treating and/or preventing schizophrenia and related psychoses
05/01/2012US8168588 Compositions comprising FGF-9 and betacellulin and methods for treating cardiac conditions
05/01/2012US8168587 Combination enzyme replacement and small molecule therapy for treatment of lysosomal storage diseases
05/01/2012US8168586 Cancer targets and uses thereof
05/01/2012US8168585 Purification of peptides from colostrum
05/01/2012US8168584 Methods of treating age-related macular degeneration by compstatin and analogs thereof
05/01/2012US8168418 Expression of HIV polypeptides and production of virus-like particles
05/01/2012US8168416 Modified lecithin-cholesterol acyltransferase enzymes
05/01/2012US8168415 Axl fusion proteins as Axl tyrosine kinase inhibitors
05/01/2012US8168233 administering to a patient with pancretitis and pain associated with pancretitis, an amylin, an amylin analog such as 25, 28, 29Pro-h-amylicn or an amylin agonist, amylin agonist is not a calcitonin and an analgesic
05/01/2012US8168230 Platelet gel comprising platelet-rich plasma, platelet activator and polymer
05/01/2012US8168206 Animal protein-free pharmaceutical compositions
05/01/2012US8168205 Streptococcus pneumoniae polypeptides
05/01/2012US8168201 Vaccines
05/01/2012US8168198 Therapeutic agent for polycystic ovary syndrome (PCOS)
05/01/2012US8168194 Fusion proteins comprising CD4 minimal modules and human immunodeficiency virus (HIV) Tat scaffold polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes
05/01/2012US8168193 Molecules, compositions, methods and kits for applications associated with flaviviruses
05/01/2012US8168190 HBV core antigen particles with multiple immunogenic components attached via peptide ligands
05/01/2012US8168189 Protein A compositions and methods of use
05/01/2012US8168187 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer
05/01/2012US8168186 Therapeutic using a bispecific antibody
05/01/2012US8168180 Methods and compositions for modulating angiogenesis
05/01/2012US8168178 Methods and compositions for regulating lymphocyte activity
05/01/2012US8168177 Method of regulating mammalian target-of-rapamycin activity by interaction between phospholipase D and Rheb
05/01/2012US8168176 CBLB for treating endotoxin-mediated disorders
05/01/2012US8168175 Pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger
05/01/2012US8168160 Anti-inflammatory fusion protein
05/01/2012US8167866 Drug delivery system for accelerated subcutaneous absorption
05/01/2012CA2706525C Novel immunoregulatory peptides, compositions, and uses thereof
05/01/2012CA2543507C Use of ghrelin and unacylated ghrelin compositions in insulin-related disease conditions
05/01/2012CA2528988C Stable, aqueous solution of human erythropoietin, not containing serum albumin
05/01/2012CA2491040C Thrombin-cleavable factor x analogues
05/01/2012CA2485217C Insulin-associated peptides with effects on cerebral health
05/01/2012CA2478902C Methods for treating mammary gland disorders
05/01/2012CA2478871C Preparations for topical skin use and treatment
05/01/2012CA2473566C Pim-3 kinase as a target for type 2 diabetes mellitus
05/01/2012CA2468583C Self-assembling multimeric binding complexes derived from ab5 toxin family members
05/01/2012CA2450548C Method for the recombinant production of peptidic antiviral fusion inhibitors, and acetylation of gb41 fragments
05/01/2012CA2438080C Gonococcal proteins and nucleic acids
05/01/2012CA2429625C Hematopoietic cell e-selectin/l-selectin ligand polypeptides and methods of use thereof
05/01/2012CA2379858C Beta-amyloid peptide inhibitors
05/01/2012CA2333466C Gbs toxin receptor
05/01/2012CA2322763C Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial uc panca antigens
05/01/2012CA2281620C Neurturin receptor
05/01/2012CA2279555C Amyloid beta protein (globular assembly and uses thereof)
04/2012
04/28/2012CA2745789A1 Applicator tips having mixing ball
04/26/2012WO2012054929A2 Use of human serum albumin to decrease antigenicity of therapeutic proteins
04/26/2012WO2012054792A2 Composition and method for immunological treatment of cancer, prevention of cancer recurrence and metastasis, and overcoming immune suppressor cells
04/26/2012WO2012054693A1 Uses of yersinia yope peptide, gene, and subparts thereof as a plague vaccine component and assays for yersinia pestis-specific t cells
04/26/2012WO2012054607A2 Treatment of diabetes using g-csf and hyperbaric oxygen
04/26/2012WO2012054584A2 Peptides for modulating t-cell activity and uses thereof
04/26/2012WO2012054565A1 Methods and compositions for modulating the wnt pathway
04/26/2012WO2012054500A2 Compositions for drug administration
04/26/2012WO2012054425A2 Biodegradable particulate formulations
04/26/2012WO2012054057A1 Alkaline phosphatase to correct insulin resistance, hyperinsulinemia, and dyslipidemia
04/26/2012WO2012053856A2 Respiratory syncytial virus vaccine composition and method for preparing same
04/26/2012WO2012053827A2 Composition containing peptide ligand bonding with cxcr2 for treating infective and inflammatory diseases
04/26/2012WO2012053622A1 Non-human animal, cell, method for evaluation of blood pressure regulator, method for evaluation of condition for regulation of blood pressure, and method for regulation of blood pressure
04/26/2012WO2012053206A1 Wdhd1 peptides and vaccines including the same
04/26/2012WO2012053200A1 C18orf54 peptides and vaccines including the same
04/26/2012WO2012052995A2 Treatment and prevention of hepatocellular carcinoma with chemokine receptor modulators
04/26/2012WO2012052629A2 Tumourigenesis biomarkers and uses for obtaining anti-metastatic compounds
04/26/2012WO2012052594A2 USE OF Dlk1 AS AN ANGIOGENESIS INHIBITOR
04/26/2012WO2012052205A1 Selective targeting of the cd40l/mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis
04/26/2012WO2012052177A1 Short peptides for enhancing muscle function
04/26/2012WO2012052060A1 Method to increase the growth velocity of human infants
04/26/2012WO2012052059A1 Method to increase the absorption of unsaturated fatty acids by human infants
04/26/2012WO2012021249A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
04/26/2012WO2012021247A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
04/26/2012WO2012009289A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases
04/26/2012WO2012006585A3 Use of interleukin-15 to treat cardiovascular diseases
04/26/2012WO2012002668A3 Novel peptide and use thereof
04/26/2012WO2011163398A3 Biomimetic peptides for bone augmentation
04/26/2012WO2011162558A9 Recombinant vector for suppressing proliferation of human papillomavirus cell including adenylate cyclase activating polypeptide 1 (pituitary) gene and pharmaceutical composition for treating human papillomavirus
04/26/2012WO2011156407A3 Glp-1 receptor agonists to treat pancreatitis
04/26/2012WO2011156242A3 Improved anti-lysophospholipid antibody design using antibody structures
04/26/2012WO2011150395A3 Nutrient compositions
1 ... 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 ... 3163